Federal Trade Commission v. Watson Pharmaceuticals, Inc.
529 F. App'x 985
CourtCourt of Appeals for the Eleventh Circuit
DecidedSeptember 9, 2013
DocketNo. 10-12729
StatusPublished
This text of 529 F. App'x 985 (Federal Trade Commission v. Watson Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Federal Trade Commission v. Watson Pharmaceuticals, Inc., 529 F. App'x 985 (11th Cir. 2013).
Opinion
[986]*986ON REMAND FROM THE SUPREME COURT OF THE UNITED STATES
The district court’s judgment, which was entered on April 21, 2010, is VACATED, and this case is REMANDED for further proceedings consistent with the Supreme Court’s opinion in F.T.C. v. Actavis, Inc., - U.S. -, 133 S.Ct. 2223, 186 L.Ed.2d 343 (2013).
Free access — add to your briefcase to read the full text and ask questions with AI
Related
F.T.C. v. Actavis, Inc.
133 S. Ct. 2223 (Supreme Court, 2013)
Cite This Page — Counsel Stack
Bluebook (online)
529 F. App'x 985, Counsel Stack Legal Research, https://law.counselstack.com/opinion/federal-trade-commission-v-watson-pharmaceuticals-inc-ca11-2013.